IP Library Granted Patent US 12,697,597
Granted Patent B2
US 12,697,597 · App. 18/051,472 · Granted Aug 4, 2026

Methods for polynucleotide synthesis

Inventors: Jeremy Lackey (Foster City, CA); David Dodd (San Francisco, CA); Stefan Pitsch (Stein am Rhein, CH)
Assignee: Twist Bioscience Corporation
B01J19/0046B01J2219/00587B01J2219/00596B01J2219/00722
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,697,597
App. No.
18/051,472
Filed
Oct 31, 2022
Granted
Aug 4, 2026
Kind
B2
Art Unit
1693
USPC
536/25.3
Abstract

Provided herein are compositions, devices, systems and methods for DNA oligomer synthesis. Further provided are devices comprising addressable electrodes controlling polynucleotide synthesis (deprotection, extension, or cleavage, etc.). The compositions, devices, systems and methods described herein provide improved synthesis, storage, density, and retrieval of biomolecule-based information.

Claims (39)

1 . A method of synthesizing a polynucleotide comprising:

coupling at least one nucleoside attached to a solid support to a protected nucleoside, wherein the protected nucleoside comprises a protecting group, wherein the protecting group comprises a branched alkenylene, wherein the solid support comprises an addressable array, and wherein the addressable array comprises a plurality of loci;

contacting an amount of a reagent with the protected nucleoside, wherein the contacting results in deprotection of the protected nucleoside; and

repeating the coupling and contacting steps to synthesize the polynucleotide.

2 . The method of claim 1 , wherein the amount of the reagent is less than about 15 mol % of the protected nucleoside.

3 . The method of claim 1 , wherein the protecting group protects a 5′ hydroxyl of the protected nucleoside.

4 . The method of claim 1 , wherein the reagent comprises a transition metal catalyst.

5 . The method of claim 4 , wherein the transition metal catalyst comprises:

a zero oxidation state;

a Pd(0) catalyst;

comprises one or more phosphine ligands; and/or

Pd(Ph 3 ) 4 .

6 . The method of claim 1 , further comprising contacting the protected nucleoside with a nucleophile.

7 . The method of claim 1 , wherein the reagent is in contact with the protected nucleoside for less than about 10 minutes.

8 . The method of claim 1 , wherein the method further comprises capping, wherein capping comprises applying acetyl chloride or acetic anhydride to the solid support.

9 . The method of claim 1 , wherein the polynucleotide is 50-300 bases in length.

10 . The method of claim 1 , further comprising applying a voltage to a solvent in fluid communication with the protected polynucleotide, wherein the voltage is applied for a duration of 0.1 seconds to 10 seconds.

11 . The method of claim 1 , wherein the protected nucleoside comprises the formula:

wherein:

R1 is a branched alkenylene;

R2 is alkylene or alkenylene, each of which is independently unsubstituted or substituted;

each R3, R4, R5, R6, R7, R8, or R9 is independently H, OH, a halogen, an O-alkyl, an N-alkyl, an O-alkyl-O-alkyl, an azide; or

R3 and R6 are taken together to form a ring; and

B is a monocyclic or bicyclic C4-6 heterocyclic ring.

12 . The method of claim 11 , wherein one or both of R3 and R4 is:

F;

OCH 3 ; or

OCH 2 CH 2 OCH 3 .

13 . The method of claim 1 , wherein the reagent comprises a Pd(0) complex with negatively charged aryl-sulfonate containing phosphine ligands.

14 . The method of claim 13 , further comprising:

applying a voltage to one or more loci to electrophoretically attract the Pd(0) complex with negatively charged phosphine ligands to selected loci to deprotect the protected nucleoside.

15 . The method of claim 1 , wherein each polynucleotide of the plurality of polynucleotides synthesized has a different sequence from another polynucleotide of the plurality of polynucleotides.

16 . The method of claim 1 , further comprising:

selectively reducing a Pd(II) precursor at one or more loci of the addressable array to generate a Pd(0) catalyst;

contacting the protected nucleoside with the Pd(0) catalyst and a nucleophile to deprotect the protected nucleoside.

17 . The method of claim 1 , wherein the plurality of polynucleotides are synthesized at a rate of about 100 nucleotides per hour.

18 . The method of claim 6 , wherein the nucleophile is N,N-dimethylbarbiturate.

19 . The method of claim 1 , further comprising an oxidation step, wherein the oxidation step comprises treatment with iodine, water, and a base, wherein the base is selected from pyridine, lutidine, or collidine.

20 . The method of claim 1 , wherein the protecting group comprising a branched alkenylene is protecting a 3′ hydroxyl of the protected nucleoside.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2024
From: LACKEY, JEREMY; DODD, DAVID; PITSCH, STEFAN
To: TWIST BIOSCIENCE CORPORATION
Reel/Frame 067140/0406 →
Continuity (2)
Provisional Application 63274397 · Nov 1, 2021
Related Publication 20230158469A1 · May 25, 2023
References Cited (348)
US 5026838A · Nojiri et al. · 1991 [cited by applicant]
US 5368823A · McGraw et al. · 1994 [cited by applicant]
US 5474796A · Brennan · 1995 [cited by applicant]
US 5534507A · Cama et al. · 1996 [cited by applicant]
US 5677195A · Winkler et al. · 1997 [cited by applicant]
US 5843767A · Beattie · 1998 [cited by applicant]
US 6013440A · Lipshutz et al. · 2000 [cited by applicant]
US 6028189A · Blanchard · 2000 [cited by applicant]
US 6093302A · Montgomery · 2000 [cited by applicant]
US 6419883B1 · Blanchard · 2002 [cited by applicant]
US 6444111B1 · Montgomery · 2002 [cited by applicant]
US 6472147B1 · Janda et al. · 2002 [cited by applicant]
US 6492107B1 · Kauffman et al. · 2002 [cited by applicant]
US 6893816B1 · Beattie · 2005 [cited by applicant]
US 7163660B2 · Lehmann · 2007 [cited by applicant]
US 7202264B2 · Ravikumar et al. · 2007 [cited by applicant]
US 8198071B2 · Goshoo et al. · 2012 [cited by applicant]
US 8486631B2 · Holt et al. · 2013 [cited by applicant]
US 8647821B2 · Castro et al. · 2014 [cited by applicant]
US 9403141B2 · Banyai et al. · 2016 [cited by applicant]
US 9409139B2 · Banyai et al. · 2016 [cited by applicant]
US 9555388B2 · Banyai et al. · 2017 [cited by applicant]
US 9677067B2 · Toro et al. · 2017 [cited by applicant]
US 9745619B2 · Rabbani et al. · 2017 [cited by applicant]
US 9765387B2 · Rabbani et al. · 2017 [cited by applicant]
US 9833761B2 · Banyai et al. · 2017 [cited by applicant]
US 9839894B2 · Banyai et al. · 2017 [cited by applicant]
US 9889423B2 · Banyai et al. · 2018 [cited by applicant]
US 9895673B2 · Peck et al. · 2018 [cited by applicant]
US 9981239B2 · Banyai et al. · 2018 [cited by applicant]
US 10053688B2 · Cox · 2018 [cited by applicant]
US 10272410B2 · Banyai et al. · 2019 [cited by applicant]
US 10384188B2 · Banyai et al. · 2019 [cited by applicant]
US 10384189B2 · Peck · 2019 [cited by applicant]
US 10417457B2 · Peck · 2019 [cited by applicant]
US 10583415B2 · Banyai et al. · 2020 [cited by applicant]
US 10618024B2 · Banyai et al. · 2020 [cited by applicant]
US 10632445B2 · Banyai et al. · 2020 [cited by applicant]
US 10639609B2 · Banyai et al. · 2020 [cited by applicant]
US 10669304B2 · Indermuhle et al. · 2020 [cited by applicant]
US 10744477B2 · Banyai et al. · 2020 [cited by applicant]
US 10754994B2 · Peck · 2020 [cited by applicant]
US 10773232B2 · Banyai et al. · 2020 [cited by applicant]
US 10844373B2 · Cox et al. · 2020 [cited by applicant]
US 10894242B2 · Marsh et al. · 2021 [cited by applicant]
US 10894959B2 · Cox et al. · 2021 [cited by applicant]
US 10907274B2 · Cox · 2021 [cited by applicant]
US 10936953B2 · Bramlett et al. · 2021 [cited by applicant]
US 10969965B2 · Malina et al. · 2021 [cited by applicant]
US 10975372B2 · Cox et al. · 2021 [cited by applicant]
US 10987648B2 · Peck et al. · 2021 [cited by applicant]
US 11185837B2 · Banyai et al. · 2021 [cited by applicant]
US 11214798B2 · Brown · 2022 [cited by applicant]
US 11263354B2 · Peck · 2022 [cited by applicant]
US 11332738B2 · Nugent et al. · 2022 [cited by applicant]
US 11332740B2 · Nugent et al. · 2022 [cited by applicant]
US 11377676B2 · Wu et al. · 2022 [cited by applicant]
US 11407837B2 · Glanville · 2022 [cited by applicant]
US 11452980B2 · Banyai et al. · 2022 [cited by applicant]
US 11492665B2 · Zeitoun et al. · 2022 [cited by applicant]
US 11492727B2 · Tabibiazar et al. · 2022 [cited by applicant]
US 11492728B2 · Sato · 2022 [cited by applicant]
US 11512347B2 · Peck · 2022 [cited by applicant]
US 20010018512A1 · Blanchard · 2001 [cited by applicant]
US 20020025561A1 · Hodgson · 2002 [cited by applicant]
US 20020045221A1 · Dellinger et al. · 2002 [cited by applicant]
US 20020094533A1 · Hess et al. · 2002 [cited by applicant]
US 20020095073A1 · Jacobs et al. · 2002 [cited by applicant]
US 20020160536A1 · Regnier et al. · 2002 [cited by applicant]
US 20020164824A1 · Xiao et al. · 2002 [cited by applicant]
US 20030120035A1 · Gao et al. · 2003 [cited by applicant]
US 20030171325A1 · Gascoyne et al. · 2003 [cited by applicant]
US 20040087008A1 · Schembri · 2004 [cited by applicant]
US 20040259146A1 · Friend et al. · 2004 [cited by applicant]
US 20050137805A1 · Lewin et al. · 2005 [cited by applicant]
US 20050227235A1 · Carr et al. · 2005 [cited by applicant]
US 20060127920A1 · Church et al. · 2006 [cited by applicant]
US 20070196834A1 · Cerrina et al. · 2007 [cited by applicant]
US 20080085511A1 · Peck et al. · 2008 [cited by applicant]
US 20080085514A1 · Peck et al. · 2008 [cited by applicant]
US 20080108149A1 · Sundararajan et al. · 2008 [cited by applicant]
US 20080227160A1 · Kool · 2008 [cited by applicant]
US 20080287320A1 · Baynes et al. · 2008 [cited by applicant]
US 20080300842A1 · Govindarajan et al. · 2008 [cited by applicant]
US 20090062129A1 · Mckernan et al. · 2009 [cited by applicant]
US 20090239759A1 · Balch · 2009 [cited by applicant]
US 20090285825A1 · Kini et al. · 2009 [cited by applicant]
US 20100004143A1 · Shibahara · 2010 [cited by applicant]
US 20100099103A1 · Hsieh et al. · 2010 [cited by applicant]
US 20100111768A1 · Banerjee et al. · 2010 [cited by applicant]
US 20100216648A1 · Staehler et al. · 2010 [cited by applicant]
US 20100311960A1 · Dellinger · 2010 [cited by applicant]
US 20110172127A1 · Jacobson et al. · 2011 [cited by applicant]
US 20110217738A1 · Jacobson · 2011 [cited by applicant]
US 20120129704A1 · Gunderson et al. · 2012 [cited by applicant]
US 20120164691A1 · Eshoo et al. · 2012 [cited by applicant]
US 20120231968A1 · Bruhn et al. · 2012 [cited by applicant]
US 20120264653A1 · Carr et al. · 2012 [cited by applicant]
US 20130017642A1 · Milgrew et al. · 2013 [cited by applicant]
US 20130017977A1 · Oleinikov · 2013 [cited by applicant]
US 20130065017A1 · Sieber · 2013 [cited by applicant]
US 20130109595A1 · Routenberg · 2013 [cited by applicant]
US 20130109596A1 · Peterson et al. · 2013 [cited by applicant]
US 20130130321A1 · Staehler et al. · 2013 [cited by applicant]
US 20130165328A1 · Previte et al. · 2013 [cited by applicant]
US 20140106394A1 · Ko et al. · 2014 [cited by applicant]
US 20140178992A1 · Nakashima et al. · 2014 [cited by applicant]
US 20150038373A1 · Banyai et al. · 2015 [cited by applicant]
US 20150120265A1 · Amirav-Drory et al. · 2015 [cited by applicant]
US 20150196917A1 · Kay et al. · 2015 [cited by applicant]
US 20160089651A1 · Banyai · 2016 [cited by applicant]
US 20160090592A1 · Banyai et al. · 2016 [cited by applicant]
US 20160096160A1 · Banyai et al. · 2016 [cited by applicant]
US 20160186166A1 · Poehmerer · 2016 [cited by examiner]
US 20160251651A1 · Banyai et al. · 2016 [cited by applicant]
US 20160303535A1 · Banyai et al. · 2016 [cited by applicant]
US 20160333340A1 · Wu · 2016 [cited by applicant]
US 20160339409A1 · Banyai et al. · 2016 [cited by applicant]
US 20160340672A1 · Banyai et al. · 2016 [cited by applicant]
US 20160354752A1 · Banyai et al. · 2016 [cited by applicant]
US 20170095785A1 · Banyai et al. · 2017 [cited by applicant]
US 20170159044A1 · Toro et al. · 2017 [cited by applicant]
US 20170327819A1 · Banyai et al. · 2017 [cited by applicant]
US 20170357752A1 · Diggans · 2017 [cited by applicant]
US 20170362589A1 · Banyai et al. · 2017 [cited by applicant]
US 20180029001A1 · Banyai et al. · 2018 [cited by applicant]
US 20180104664A1 · Fernandez · 2018 [cited by applicant]
US 20180142289A1 · Zeitoun et al. · 2018 [cited by applicant]
US 20180253563A1 · Peck et al. · 2018 [cited by applicant]
US 20180264428A1 · Banyai et al. · 2018 [cited by applicant]
US 20180282721A1 · Cox et al. · 2018 [cited by applicant]
US 20180326388A1 · Banyai et al. · 2018 [cited by applicant]
US 20190244109A1 · Bramlett · 2019 [cited by examiner]
US 20190314783A1 · Banyai et al. · 2019 [cited by applicant]
US 20190352635A1 · Toro et al. · 2019 [cited by applicant]
US 20190366293A1 · Banyai et al. · 2019 [cited by applicant]
US 20190366294A1 · Banyai et al. · 2019 [cited by applicant]
US 20200017908A1 · Milton et al. · 2020 [cited by applicant]
US 20200102611A1 · Zeitoun et al. · 2020 [cited by applicant]
US 20200156037A1 · Banyai et al. · 2020 [cited by applicant]
US 20200181667A1 · Wu et al. · 2020 [cited by applicant]
US 20200222875A1 · Peck et al. · 2020 [cited by applicant]
US 20200283760A1 · Nugent et al. · 2020 [cited by applicant]
US 20200299322A1 · Indermuhle et al. · 2020 [cited by applicant]
US 20200299684A1 · Toro et al. · 2020 [cited by applicant]
US 20200330953A1 · Banyai et al. · 2020 [cited by applicant]
US 20210002710A1 · Gantt et al. · 2021 [cited by applicant]
US 20210040476A1 · Cox et al. · 2021 [cited by applicant]
US 20210071168A1 · Nugent et al. · 2021 [cited by applicant]
US 20210102192A1 · Tabibiazar et al. · 2021 [cited by applicant]
US 20210102195A1 · Sato et al. · 2021 [cited by applicant]
US 20210102198A1 · Cox et al. · 2021 [cited by applicant]
US 20210115594A1 · Cox et al. · 2021 [cited by applicant]
US 20210129108A1 · Marsh et al. · 2021 [cited by applicant]
US 20210142182A1 · Bramlett et al. · 2021 [cited by applicant]
US 20210170356A1 · Peck et al. · 2021 [cited by applicant]
US 20210179724A1 · Sato et al. · 2021 [cited by applicant]
US 20210180046A1 · Cox et al. · 2021 [cited by applicant]
US 20210189082A1 · Berti et al. · 2021 [cited by applicant]
US 20210207197A1 · Gantt et al. · 2021 [cited by applicant]
US 20210231609A1 · Gordon et al. · 2021 [cited by applicant]
US 20210332078A1 · Wu · 2021 [cited by applicant]
US 20210348220A1 · Zeitoun et al. · 2021 [cited by applicant]
US 20210355194A1 · Sato et al. · 2021 [cited by applicant]
US 20210395344A1 · Sato et al. · 2021 [cited by applicant]
US 20220032256A1 · Lackey et al. · 2022 [cited by applicant]
US 20220064206A1 · Fernandez · 2022 [cited by examiner]
US 20220064313A1 · Sato et al. · 2022 [cited by applicant]
US 20220064628A1 · Toro et al. · 2022 [cited by applicant]
US 20220106586A1 · Nugent et al. · 2022 [cited by applicant]
US 20220106590A1 · Arbiza et al. · 2022 [cited by applicant]
US 20220135690A1 · Sato et al. · 2022 [cited by applicant]
US 20220135965A1 · Gantt et al. · 2022 [cited by applicant]
US 20220138354A1 · Peck · 2022 [cited by applicant]
US 20220145289A1 · Lackey et al. · 2022 [cited by applicant]
US 20220206001A1 · Sato · 2022 [cited by applicant]
US 20220243195A1 · Nugent et al. · 2022 [cited by applicant]
US 20220246236A1 · Amirav-Drory · 2022 [cited by applicant]
US 20220259319A1 · Sato et al. · 2022 [cited by applicant]
US 20220259638A1 · Brown · 2022 [cited by applicant]
US 20220277808A1 · Arbiza et al. · 2022 [cited by applicant]
US 20220281989A1 · Glanville · 2022 [cited by applicant]
US 20220307010A1 · Sato et al. · 2022 [cited by applicant]
US 20220315971A1 · Wu et al. · 2022 [cited by applicant]
US 20220323924A1 · Lackey et al. · 2022 [cited by applicant]
US 20220325276A2 · Banyai et al. · 2022 [cited by applicant]
US 20220325278A1 · Nugent et al. · 2022 [cited by applicant]
US 20220348659A1 · Sato et al. · 2022 [cited by applicant]
US 20220356463A1 · Shen et al. · 2022 [cited by applicant]
US 20220356468A1 · Sato et al. · 2022 [cited by applicant]
US 20220411784A1 · Sato et al. · 2022 [cited by applicant]
US 20230002478A1 · Sato et al. · 2023 [cited by applicant]
CN 101277758A · 2008 [cited by applicant]
EP 3030682A2 · 2016 [cited by applicant]
JP H07505530A · 1995 [cited by applicant]
JP 2001518086A · 2001 [cited by applicant]
JP 2002538790A · 2002 [cited by applicant]
JP 2004268394A · 2004 [cited by applicant]
JP 2006503586A · 2006 [cited by applicant]
JP 2007314746A · 2007 [cited by applicant]
JP 2008214343A · 2008 [cited by applicant]
JP 2009294195A · 2009 [cited by applicant]
JP 2012507513A · 2012 [cited by applicant]
JP 2016527313A · 2016 [cited by applicant]
WO WO9320242A1 · 1993 [cited by applicant]
WO WO02072791A2 · 2002 [cited by applicant]
WO WO2004039953A2 · 2004 [cited by applicant]
WO WO2005059096A2 · 2005 [cited by applicant]
WO WO2008054543A2 · 2008 [cited by applicant]
WO WO2008063135A1 · 2008 [cited by applicant]
WO WO2010053443A1 · 2010 [cited by applicant]
WO WO2011109031A1 · 2011 [cited by applicant]
WO WO2012078312A2 · 2012 [cited by applicant]
WO WO2012154201A1 · 2012 [cited by applicant]
WO WO2014021938A1 · 2014 [cited by applicant]
WO WO2015021080A2 · 2015 [cited by applicant]
WO 2020020608A1 · 2020 [cited by applicant]
WO WO2020010560A1 · 2020 [cited by applicant]
WO WO2022010934A2 · 2022 [cited by applicant]
WO WO2022076326A1 · 2022 [cited by applicant]
WO WO2022086866A1 · 2022 [cited by applicant]
WO WO2022087293A1 · 2022 [cited by applicant]
WO WO2022098662A2 · 2022 [cited by applicant]
WO WO2022159620A1 · 2022 [cited by applicant]
WO WO2022178137A1 · 2022 [cited by applicant]
WO WO2022204309A1 · 2022 [cited by applicant]
WO WO2022204316A2 · 2022 [cited by applicant]
WO WO2022217004A1 · 2022 [cited by applicant]
WO WO2022235579A1 · 2022 [cited by applicant]
WO WO2022235584A1 · 2022 [cited by applicant]
WO WO2022271884A2 · 2022 [cited by applicant]
Larpent, C., Patin, H. Tetrahedron. 1988. vol 44, No. 19, pp. 6107 to 6118. (Year: 1988). [cited by examiner]
Hayakawa, Y., et al. J. Am. Chem. Soc. 1990, 112, 1691-1696. (Year: 1990). [cited by examiner]
PCT/US2022/048456 International Search Report and Written Opinion Mar. 3, 2023. [cited by applicant]
Agbavwe et al.: Efficiency, Error and Yield in Light-Directed Maskless Synthesis of DNA Microarrays. Journal of Nanobiotechnology. 9(57):1-17 (2011). [cited by applicant]
Arkles et al.: The Role of Polarity in the Structure of Silanes Employed in Surface Modification. Silanes and Other Coupling Agents. 5:51-64 (2009). [cited by applicant]
ATDBio. Nucleic Acid Structure, Nucleic Acids Book, 9 pages, published on Jan. 22, 2005. from: http://www.atdbio.com/content/5/Nucleic-acid-structure. [cited by applicant]
ATDBio. Solid-Phase Oligonucleotide Synthesis, Nucleic Acids Book, 20 pages, Published on Jul. 31, 2011. from: http://www.atdbio.com/content/17/Solid-phase-oligonucleotide-synthesis. [cited by applicant]
Berg: Biochemistry. 5th ED. New York (2002) 148-149. [cited by applicant]
Blanchard et al.: High-Density Oligonucleotide Arrays. Biosensors & Bioelectronics, 11(6/7):687-690 (1996). [cited by applicant]
Buermans et al.: Next Generation sequencing technology: Advances and applications, Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1842:1931-1941 (2014). [cited by applicant]
Cheng et al.: High throughput parallel synthesis of oligonucleotides with 1536 channel synthesizer. Nucleic Acids Res. 30(18):e93 (2002). [cited by applicant]
Cleary et al.: Production of complex nucleic acid libraries using highly parallel in situ oligonucleotide synthesis. Nat Methods. 1(3):241-248 (2004). [cited by applicant]
Cohen et al.: Human population: The next half century. Science. 302:1172-1175 (2003). [cited by applicant]
Cruse et al.: Atlas of Immunology. Third Edition. Boca Raton:CRC Press (pp. 282-283) (2010). [cited by applicant]
Elsik et al.: The Genome sequence of taurine cattle: A window of ruminant biology and evolution. Science. 324:522-528 (2009). [cited by applicant]
Fodor et al.: Light-directed, spatially addressable parallel chemical synthesis. Science. 251(4995):767-773 (1991). [cited by applicant]
Gao et al.: A method for the generation of combinatorial antibody libraries using pIX phage display. PNAS 99(20):12612-12616 (2002). [cited by applicant]
GE Healthcare. AKTA oligopilot plus. Data File 18-114-66 ADC. 8 pages (2006). [cited by applicant]
GE Healthcare. Robust and cost-efficient oligonucleotide synthesis. Application Note 28-4058-08 AA. 4 pages (2005). [cited by applicant]
Gibson et al.: Creation of a Bacterial Cell Controlled by A Chemically Synthesized Genome. Science. 329(5989):52-56 (2010). [cited by applicant]
Hayakawa et al.: Allyloxycarbonyl group: a versatile blocking group for nucleotide synthesis. J. Org. Chem. 51(12):2400-2402 (1986). [cited by applicant]
Hudson: Matrix Assisted Synthetic Transformations: A Mosaic of Diverse Contributions. Journal of Combinatorial Chemistry. 1(6):403-457 (1999). [cited by applicant]
Kong et al.: Parallel gene synthesis in a microfluidic device. Nucleic Acids Res. 35(8):e61 (2007). [cited by applicant]
Kosuri and Church. Large-scale de novo DNA synthesis: technologies and applications. Nature Methods. 11:499-507 (2014) Available at: http://www.nature.com/nmeth/journal/v11/n5/full/nmeth.2918.html. [cited by applicant]
Kosuri et al.: A scalable gene synthesis by selective amplification of DNA pools from high-fidelity microchips. Nature Biotechnology. 28:1295-1299 (2010). [cited by applicant]
Kosuri et al.: A scalable gene synthesis platform using high-fidelity DNA microchips Nat.Biotechnol. 28(12):1295-1299 (2010). [cited by applicant]
Krayden, Inc.: A Guide to Silane Solutions. Silane coupling agents. 7 pages. Published on May 31, 2005 at: http://krayden.com/pdf/xia_silane_chemistry.pdf. [cited by applicant]
Lausted et al.: POSaM: a fast, flexible, open-source, inkjet oligonucleotide synthesizer and microarrayer. Genome Biology. 5:R58, 17 pages (2004) available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC507883/. [cited by applicant]
Lebl et al.: Economical Parallel Oligonucleotide and Peptide Synthesizer—Pet Oligator. Int. J. Peptide Res. Ther. 13(1-2):367-376 (2007). [cited by applicant]
Leproust et al.: Synthesis of high-quality libraries of long (150mer) oligonucleotides by a novel depurination controlled process. Nucleic Acids Research. 38(8):2522-2540 (2010). [cited by applicant]
Lewontin and Harti, Population genetics in forensic DNA typing. Science, 254:1745-1750, 1991. [cited by applicant]
Lindstrom et al.: An orthogonal oligonucleotide protecting group strategy that enables assembly of repetitive or highly structured DNAs. Nucleic Acids Research. 30(19):e101 (2002). [cited by applicant]
Ma et al.: DNA synthesis, assembly and application in synthetic biology. Current Opinion in Chemical Biology. 16:260-267 (2012). [cited by applicant]
Ma et al.: Versatile surface functionalization of cyclic olefin copolymer (COC) with sputtered SiO2 thin film for potential BioMEMS applications. Journal of Materials Chemistry. 11 pages (2009). [cited by applicant]
Mazor et al.: Isolation of Full-Length IgG Antibodies from Combinatorial Libraries Expressed in [cited by applicant]
McBride & Caruthers. An investigation of several deoxynucleoside phosphoramidites useful for synthesizing deoxyoligonucleotides. Tetrahedron Lett. 24:245-248 (1983). [cited by applicant]
Mitra et al.: In situ localized amplification and contact replication of many individual DNA molecules. Nucleic Acids Res. 27(24):e34 (1999). [cited by applicant]
Morin et al.: Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing. Biotechniques. 45:81-94 (2008). [cited by applicant]
Opposition to European Patent No. 3030682 filed Mar. 3, 2021. [cited by applicant]
PCT/US2014/049834 International Preliminary Report on Patentability dated Feb. 18, 2016. [cited by applicant]
PCT/US2014/049834 International Search Report and Written Opinion mailed Mar. 19, 2015. [cited by applicant]
PCT/US2014/049834 Invitation to Pay Additional Fees mailed Jan. 5, 2015. [cited by applicant]
Pirrung. How to make a DNA chip. Angew. Chem. Int. Ed. 41:1276-1289 (2002). [cited by applicant]
Pray. Discovery of DNA Structure and Function: Watson and Crick. Nature Education.6 pages (2008) available at: http://www.nature.com/scitable/topicpage/discovery-of-dna-structure-and-function-watson-397. [cited by applicant]
Quan et al.: Parallel on-chip gene synthesis and application to optimization of protein expression. Nature Biotechnology. 29:449-452 (2011). [cited by applicant]
Rafalski and Morgante. Corn and humans: recombination and linkage disequilibrium in two genomes of similar size. Trends in Genetics. 20(2):103-111 (2004). [cited by applicant]
Rogozin et al.: Origin and evolution of spliceosomal introns. Biology Direct, 7:11 (2012). [cited by applicant]
Saaem et al.: In situ synthesis of DNA microarray on functionalized cyclic olefin copolymer substrate ACS Applied Materials & Interfaces. 2(2):491-497 (2010). [cited by applicant]
Sargolzaei et al.: Extent of linkage disequilibrium in Holstein cattle in North America. J.Dairy Science. 91:2106-2117 (2007). [cited by applicant]
Srivannavit et al.: Design and fabrication of microwell array chips for a solution-based, photogenerated acid-catalyzed parallel oligonucleotide DNA synthesis. Sensors and Actuators A. 116:150-160 (2004). [cited by applicant]
Steel. The Flow-Thru Chip A Three-dimensional biochip platform. In: Schena, Microarray Biochip Technology, Chapter 5, Natick, MA: Eaton Publishing, 2000, 33 pages. [cited by applicant]
Sun et al.: Preparation of N3-thymidine-butylene-N3-thymidine interstrand cross-linked DNA via an orthogonal deprotection strategy. Tetrahedron. 68(38):7787-7793 (2012). [cited by applicant]
Taylor et al.: Impact of surface chemistry and blocking strategies on DNA microarrays. Nucleic Acids Research, 31(16):e87 19 pages (2003). [cited by applicant]
Tian et al.: Accurate multiplex gene synthesis from programmable DNA microchips. Nature. 432(7020):1050-1054 (2004). [cited by applicant]
U.S. Appl. No. 14/452,429 Notice of Allowance dated Jun. 7, 2016. [cited by applicant]
U.S. Appl. No. 14/452,429 Office Action mailed Apr. 9, 2015. [cited by applicant]
U.S. Appl. No. 14/452,429 Office Action mailed Oct. 21, 2015. [cited by applicant]
U.S. Appl. No. 14/452,429 Restriction Requirement mailed Dec. 12, 2014. [cited by applicant]
U.S. Appl. No. 14/885,962 Notice of Allowance dated Nov. 8, 2017 and Sep. 29, 2017. [cited by applicant]
U.S. Appl. No. 14/885,962 Office Action dated Dec. 16, 2016. [cited by applicant]
U.S. Appl. No. 14/885,962 Office Action dated Sep. 8, 2016. [cited by applicant]
U.S. Appl. No. 14/885,962 Restriction Requirement dated Mar. 1, 2016. [cited by applicant]
U.S. Appl. No. 14/885,963 Notice of Allowance dated May 24, 2016. [cited by applicant]
U.S. Appl. No. 14/885,963 Office Action dated Feb. 5, 2016. [cited by applicant]
U.S. Appl. No. 14/885,965 Office Action dated Aug. 28, 2018. [cited by applicant]
U.S. Appl. No. 14/885,965 Office Action dated Aug. 30, 2017. [cited by applicant]
U.S. Appl. No. 14/885,965 Office Action dated Feb. 10, 2017. [cited by applicant]
U.S. Appl. No. 14/885,965 Office Action dated Feb. 18, 2016. [cited by applicant]
U.S. Appl. No. 14/885,965 Office Action dated Jan. 4, 2018. [cited by applicant]
U.S. Appl. No. 14/885,965 Office Action dated Jul. 7, 2016. [cited by applicant]
U.S. Appl. No. 15/187,714 Final Office Action dated Sep. 17, 2019. [cited by applicant]
U.S. Appl. No. 15/187,714 Office Action dated Apr. 4, 2019. [cited by applicant]
U.S. Appl. No. 15/187,714 Restriction Requirement dated Sep. 17, 2018. [cited by applicant]
U.S. Appl. No. 15/187,721 Notice of Allowance dated Dec. 7, 2016. [cited by applicant]
U.S. Appl. No. 15/187,721 Office Action dated Oct. 14, 2016. [cited by applicant]
U.S. Appl. No. 15/233,835 Notice of Allowance dated Oct. 4, 2017. [cited by applicant]
U.S. Appl. No. 15/233,835 Office Action dated Feb. 8, 2017. [cited by applicant]
U.S. Appl. No. 15/233,835 Office Action dated Jul. 26, 2017. [cited by applicant]
U.S. Appl. No. 15/233,835 Restriction Requirement dated Nov. 4, 2016. [cited by applicant]
U.S. Appl. No. 15/245,054 Notice of Allowance dated Dec. 14, 2017. [cited by applicant]
U.S. Appl. No. 15/245,054 Office Action dated Mar. 21, 2017. [cited by applicant]
U.S. Appl. No. 15/245,054 Office Action dated Oct. 19, 2016. [cited by applicant]
U.S. Appl. No. 15/377,547 Final Office Action dated Feb. 8, 2019. [cited by applicant]
U.S. Appl. No. 15/377,547 Office Action dated Jul. 27, 2018. [cited by applicant]
U.S. Appl. No. 15/377,547 Office Action dated Mar. 24, 2017. [cited by applicant]
U.S. Appl. No. 15/377,547 Office Action dated Nov. 30, 2017. [cited by applicant]
U.S. Appl. No. 15/602,991 Final Office Action dated Dec. 13, 2018. [cited by applicant]
U.S. Appl. No. 15/602,991 Notice of Allowance dated Oct. 25, 2017. [cited by applicant]
U.S. Appl. No. 15/602,991 Office Action dated May 31, 2018. [cited by applicant]
U.S. Appl. No. 15/602,991 Office Action dated May 31, 2019. [cited by applicant]
U.S. Appl. No. 15/602,991 Office Action dated Sep. 21, 2017. [cited by applicant]
U.S. Appl. No. 15/603,013 Final Office Action dated Nov. 6, 2019. [cited by applicant]
U.S. Appl. No. 15/603,013 Office Action dated Jan. 30, 2018. [cited by applicant]
U.S. Appl. No. 15/603,013 Office Action dated Jul. 10, 2018. [cited by applicant]
U.S. Appl. No. 15/603,013 Office Action dated Jun. 26, 2019. [cited by applicant]
U.S. Appl. No. 15/603,013 Office Action dated Oct. 20, 2017. [cited by applicant]
U.S. Appl. No. 15/729,564 Final Office Action dated Dec. 13, 2018. [cited by applicant]
U.S. Appl. No. 15/729,564 Office Action dated Jan. 8, 2018. [cited by applicant]
U.S. Appl. No. 15/729,564 Office Action dated Jun. 6, 2018. [cited by applicant]
U.S. Appl. No. 15/729,564 Office Action dated May 30, 2019. [cited by applicant]
U.S. Appl. No. 15/991,992 Office Action dated May 21, 2020. [cited by applicant]
U.S. Appl. No. 15/991,992 Restriction Requirement dated Mar. 10, 2020. [cited by applicant]
U.S. Appl. No. 16/039,256 Final Office Action dated Mar. 30, 2021. [cited by applicant]
U.S. Appl. No. 16/039,256 Office Action dated Aug. 20, 2020. [cited by applicant]
U.S. Appl. No. 16/039,256 Office Action dated May 10, 2022. [cited by applicant]
U.S. Appl. No. 16/039,256 Restriction Requirement dated May 18, 2020. [cited by applicant]
U.S. Appl. No. 16/409,608 Office Action dated Sep. 9, 2019. [cited by applicant]
U.S. Appl. No. 16/535,777 Final Office Action dated Oct. 20, 2020. [cited by applicant]
U.S. Appl. No. 16/535,777 Office Action dated Feb. 8, 2021. [cited by applicant]
U.S. Appl. No. 16/535,777 Office Action dated Jan. 23, 2020. [cited by applicant]
U.S. Appl. No. 16/535,779 First Action Interview dated Feb. 10, 2020. [cited by applicant]
U.S. Appl. No. 16/737,401 Final Office Action dated Jun. 13, 2022. [cited by applicant]
U.S. Appl. No. 16/737,401 Office Action dated Jan. 5, 2022. [cited by applicant]
U.S. Appl. No. 16/737,401 Restriction Requirement dated Nov. 15, 2021. [cited by applicant]
Van Tassell et al.: SNP discovery and allele frequency estimation by deep sequencing of reduced representation libraries. Nature Methods. 5:247-252 (2008). [cited by applicant]
Vitra: Solid-phase synthesis of base-sensitive oligonucleotides. ARKIVOC (iii) 54-83 http://www.arkat-usa.org/get-file/26185 (2009). [cited by applicant]
Xu et al.: Design of 240,000 orthogonal 25mer DNA barcode probes. PNAS. 106(7):2289-2294 (2009). [cited by applicant]